Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment

References

• MeyerMJFlemingJMAliMAPeseskyMWGinsburgEVonderhaarBKDynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell linesBreast Cancer Res200911R8219906290
   PubMed Web of Science ®Google Scholar
• SheridanCKishimotoHFuchsRKCD44+/CD24− breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasisBreast Cancer Res20068R5917062128
   PubMed Web of Science ®Google Scholar
• TiezziDGValejoFAMaranaHRCD44(+)/CD24(−) cells and lymph node metastasis in stage I and II invasive ductal carcinoma of the breastMed Oncol Epub June 29, 2011
   Web of Science ®Google Scholar
• JohnstonSRTargeting downstream effectors of epidermal growth factor receptor/HER2 in breast cancer with either farnesyltransferase inhibitors or mTOR antagonistsInt J Gynecol Cancer20061654354817010069
   PubMedGoogle Scholar
• NandaRTargeting the human epidermal growth factor receptor 2 (HER2) in the treatment of breast cancer: recent advances and future directionsRev Recent Clin Trials2007211111618473995
   PubMedGoogle Scholar
• PiechockiMPYooGHDibbleySKLonardoFBreast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neuCancer Res2007676825684317638894
   PubMed Web of Science ®Google Scholar
• ReidAVidalLShawHde BonoJDual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu)Eur J Cancer20074348148917208435
   PubMed Web of Science ®Google Scholar
• SantinADBelloneSRomanJJMcKenneyJKPecorelliSTrastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neuInt J Gynaecol Obstet200810212813118555254
   PubMed Web of Science ®Google Scholar
• FreudenbergJAWangQKatsumataMDrebinJNagatomoIGreeneMIThe role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapiesExp Mol Pathol20098711119450579
   PubMed Web of Science ®Google Scholar
• Diermeier-DaucherSBreindlSBuchholzSOrtmannOBrockhoffGModular anti-EGFR and anti-Her2 targeting of SK-BR-3 and BT474 breast cancer cell lines in the presence of ErbB receptor-specific growth factorsCytometry A201179A68469321786419
   PubMed Web of Science ®Google Scholar
• LiuTYacoubRTaliaferro-SmithLDCombinatorial effects of lapatinib and rapamycin in triple-negative breast cancer cellsMol Cancer Ther2011101460146921690228
   PubMed Web of Science ®Google Scholar
• MassarwehSOsborneCKCreightonCJTamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic functionCancer Res20086882683318245484
   PubMed Web of Science ®Google Scholar
• YonesakaKZejnullahuKOkamotoIActivation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximabSci Transl Med2011399ra8699ra86
   PubMed Web of Science ®Google Scholar
• ChenYJHuangWCWeiYLElevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cellsPLoS One20116e2142821731744
   PubMed Web of Science ®Google Scholar
• JinKKongXShahTPenetMFThe HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathwayProc Natl Acad Sci U S A Epub June 20, 2011
   Web of Science ®Google Scholar
• BrandTMIidaMWheelerDLMolecular mechanisms of resistance to the EGFR monoclonal antibody cetuximabCancer Biol Ther20111177779221293176
   PubMed Web of Science ®Google Scholar
• IdowuMOKmieciakMDumurCCD44(+)/CD24(−/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcomeHum Pathol Epub August 10, 2011
   Web of Science ®Google Scholar
• BatesRCEdwardsNSBurnsGFFisherDEA CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cellsCancer Res2001615275528311431370
   PubMed Web of Science ®Google Scholar
• ShenSYangWWangZTumor-initiating cells are enriched in CD44 population in murine salivary gland tumorPLoS One20116e2328221858056
   PubMed Web of Science ®Google Scholar
• OuhtitAAbd ElmageedZYAbdrabohMELioeTFRajMHIn vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liverAm J Pathol20071712033203917991717
   PubMed Web of Science ®Google Scholar
• Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A20031003983398812629218
   PubMed Web of Science ®Google Scholar
• FaberABarthCHörmannKCD44 as a stem cell marker in head and neck squamous cell carcinomaOncol Rep20112632163221617876
   PubMed Web of Science ®Google Scholar
• ChikamatsuKIshiiHTakahashiGResistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cellsHead Neck Epub April 5, 2011
   Web of Science ®Google Scholar
• KokkoLLHurmeSMaulaSMSignificance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinomaOral Oncol20114751051621514878
   PubMed Web of Science ®Google Scholar
• ZhaoJSLiWJGeDTumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44PLoS One20116e2141921731740
   PubMed Web of Science ®Google Scholar
• SuJXuXHHuangQIdentification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell lineArch Med Res201142152121376257
   PubMed Web of Science ®Google Scholar
• ZhangCLiCHeFCaiYYangHIdentification of CD44+CD24+ gastric cancer stem cellsJ Cancer Res Clin Oncol Epub September 1, 2011
   Web of Science ®Google Scholar
• ChenKLPanFJiangHHighly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44 (high) metastatic subset in HCT116 colon cancer cellsClin Exp Metastasis Epub July 13, 2011
   Web of Science ®Google Scholar
• FangXJJiangHZhaoXPJiangWMThe role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7BMC Cancer20111129021749678
   PubMed Web of Science ®Google Scholar
• PhucPVNhanPLNhungTHDownregulation of CD44 reduces doxorubicin resistance of CD44CD24 breast cancer cellsOnco Targets Ther20114717821792314
   PubMed Web of Science ®Google Scholar
• PhamPVPhanNLNguyenNTDifferentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapyJ Transl Med2011920922152097
   PubMed Web of Science ®Google Scholar
• AbdrabohMEGaurRLHollenbachADSandquistDRajMHOuhtitASurvivin is a novel target of CD44-promoted breast tumor invasionAm J Pathol201117955556321718681
   PubMed Web of Science ®Google Scholar
• SubramaniamVVincentIRGilakjanMJothySSuppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapyExp Mol Pathol20078333234017945212
   PubMed Web of Science ®Google Scholar
• LiCZLiuBWenZQLiHYInhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivoFolia Biol (Praha)20085418018619393131
   PubMed Web of Science ®Google Scholar
• HuangXShengYGuanMCo-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasisSurg Oncol Epub July 14, 2011
   Web of Science ®Google Scholar
• RakJMitsuhashiYBaykoLMutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesisCancer Res199555457545807553632
   PubMed Web of Science ®Google Scholar
• Antón AparicioLMCassinello EspinosaJGarcía CampeloRGómez VeigaFDíaz PradoSAparicio GallegoGProstate carcinoma and stem cellsClin Transl Oncol20079667617329217
   PubMed Web of Science ®Google Scholar
• EramoALottiFSetteGIdentification and expansion of the tumorigenic lung cancer stem cell populationCell Death Differ20081550451418049477
   PubMed Web of Science ®Google Scholar
• GlinskyGVStem cell origin of death-from-cancer phenotypes of human prostate and breast cancersStem Cell Rev20073799317873385
   PubMed Web of Science ®Google Scholar
• LiCHeidtDGDalerbaPIdentification of pancreatic cancer stem cellsCancer Res20076710301037200717283135
   PubMed Web of Science ®Google Scholar
• PrinceMESivanandanRKaczorowskiAIdentification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinomaProc Natl Acad Sci U S A200710497397817210912
   PubMed Web of Science ®Google Scholar
• SeoDCSungJMChoHJGene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cellsMol Cancer200767518034892
   PubMed Web of Science ®Google Scholar
• VorechovskýIBenediktssonKPToftgårdRThe patched/hedgehog/smoothened signalling pathway in human breast cancer: no evidence for H133Y SHH, PTCH, and SMO mutationsEur J Cancer19993571171310505029
   PubMed Web of Science ®Google Scholar
• SorianoJVUyttendaeleHKitajewskiJMontesanoRExpression of an activated Notch4(int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitroInt J Cancer20008665265910797286
   PubMed Web of Science ®Google Scholar
• KellyOGPinsonKISkarnesWCThe Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in miceDevelopment20041312803281515142971
   PubMed Web of Science ®Google Scholar
• HuelskenJVogelRBrinkmannVErdmannBBirchmeierCBirchmeierWRequirement for beta-catenin in anterior-posterior axis formation in miceJ Cell Biol200014856757810662781
   PubMed Web of Science ®Google Scholar
• CattoglioCFacchiniGSartoriDHot spots of retroviral integration in human CD34+ hematopoietic cellsBlood20071101770177817507662
   PubMed Web of Science ®Google Scholar
• MontiniECesanaDSchmidtMHematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integrationNat Biotechnol20062468769616732270
   PubMed Web of Science ®Google Scholar
• DeVitaVTJrYoungRCCanellosGPCombination versus single agent chemotherapy: a review of the basis for selection of drug treatment of cancerCancer19753598110162854
   PubMed Web of Science ®Google Scholar
• EvansPMAnatomical imaging for radiotherapyPhys Med Biol200853R151R19118495981
   PubMed Web of Science ®Google Scholar
• OlivottoMDello SbarbaPEnvironmental restrictions within tumor ecosystems select for a convergent, hypoxia-resistant phenotype of cancer stem cellsCell Cycle2008717618718256528
   PubMed Web of Science ®Google Scholar
• BlagosklonnyMVResearch by retrieving experimentsCell Cycle200761277128317525526
   PubMed Web of Science ®Google Scholar
• OttewellPDMönkkönenHJonesMLefleyDVColemanREHolenIAntitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancerJ Natl Cancer Inst20081001167117818695136
   PubMed Web of Science ®Google Scholar
• XieZChoongPFPoonLFInhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasionCancer Chemother Pharmacol20086294995718259754
   PubMed Web of Science ®Google Scholar
• HenryJCParkJKJiangJmiR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell linesBiochem Biophys Res Commun201040312012521055388
   PubMed Web of Science ®Google Scholar
• YangKTangYHabermehlGKIczkowskiKAStable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivityBMC Cancer2010101620074368
   PubMed Web of Science ®Google Scholar
• KrauseDSLazaridesKvon AndrianUHVan EttenRARequirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cellsNat Med2006121175118016998483
   PubMed Web of Science ®Google Scholar
• PontaHShermanLHerrlichPACD44: from adhesion molecules to signaling regulatorsNat Rev Mol Cell Biol20034334512511867
   PubMed Web of Science ®Google Scholar
• ShipitsinMCampbellLLArganiPMolecular definition of breast tumor heterogeneityCancer Cell20071125927317349583
   PubMed Web of Science ®Google Scholar
• ShiYTianYZhouYQInhibition of malignant activities of nasopharyngeal carcinoma cells with high expression of CD44 by siRNAOncol Rep20071839740317611662
   PubMed Web of Science ®Google Scholar
• JodJYShiYZhouYQExperimental siCD44-targeted therapy of human nasopharyngeal carcinoma mediated by adenovirusZhongguo Yi Xue Ke Xue Yuan Xue Bao200729626630 Chinese18051718
   PubMedGoogle Scholar
• BessisNGarciaCozarFJBoissierMCImmune responses to gene therapy vectors: influence on vector function and effector mechanismsGene Ther200411S10S1715454952
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-AbinaSVon KalleCSchmidtMLMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1Science200330241541914564000
   PubMed Web of Science ®Google Scholar
• SchroderARShinnPChenHBerryCEckerJRBushmanFHIV-1 integration in the human genome favors active genes and local hotspotsCell200211052152912202041
   PubMed Web of Science ®Google Scholar
• MitchellRSBeitzelBFSchroderARRetroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferencesPLoS Biol20042E23415314653
   PubMed Web of Science ®Google Scholar
• JakobssonJLundbergCLentiviral vectors for use in the central nervous systemMol Ther20061348449316403676
   PubMed Web of Science ®Google Scholar